AUPH

Aurinia Pharmaceuticals Inc.

Contracts

Total Value

Stock Metrics

7.5%

Short % Float

9.4d to cover · Moderate squeeze

59.9%

Inst % Float

10 holders · 2026-06-30

Tang Capital Manag

Top Holder

9.2% of float

126.2M sh

Public Float

25/100

Dilution Score

Low

30 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

25/100

LOW

Inst: 59.92% · Top: Tang Capital Management, LLC

Biotech Analytics

Nephrology

14.69

Squeeze risk: MODERATEBiotech Grade: F

Insider Buying0

Publications100

Dilution Risk25

Clinical Trials17

Short Interest30